|
|
|
|
|
|
| Building the Drug Safety Body of Knowledge | InterAction Meeting Executive Summits
Spring Meeting, Philadelphia (25-26 April 2005) - Full Proceedings available on Website
Confidence in Safety Sessions held at Autumn 2005 InterAction Meetings
Philadelphia (11 October 2005) & Basel, Switzerland (9 November 2005)
Drug Safety Workshops, Oxford University, Oxford, UK (3-5 July 2006) & Bryn Mawr College, Philadelphia (16-19 October 2006) | |
The goal of this program is to enhance the organizational appreciation and use of drug safety knowledge throughout product development, clinical use and marketing. More specifically, to look at ways to enhance drug safety knowledge transfer to and from R&D teams; to enhance safety knowledge transfer from clinical research to pharmacovigilance; to identify effective approaches for application of new technologies in drug safety-related decision making and safety signal detection; and to enrich the practice of making drug safety decisions under uncertainty.
Discussion leaders include Sidney Kahn, President, Pharmacovigilance & Risk Management, Inc.; Sheryl Torr-Brown, Head of Knowledge Management & Technology, World-Wide Safety Sciences, Pfizer; Peter Elkin, Professor of Medicine, Mayo Clinic; Jim Averback, President, Life Science Integration Partners; Douglas Weidner, President, International Knowledge Management Institute; Jeff Spitzner, Chief Scientific Officer, Rescentris; Eric Neumann, Life Sciences Group, w3c; Saad Shakir, Director, Drug Safety Research Unit (DSRU), UK, A. Leander Fontaine, President, pharmiceutics
» A Dynamic Approach to Industry Collaboration
» What We Want to Achieve & How We're Going About It
» Building the Drug Safety Body of Knowledge (Program Outline)
» Confidence in Safety (Autumn 2005 Meetings Program)
» Discussion Leaders
» Abstracts
|
|
|
Risk Management, Labeling Decision-Making,
Personalized Medicine, and Knowledge-based Clinical Decision Support | | Interactive pragmatic workshops and
forum led by our world-leading medical faculty instructors
a 3 Day InnovationWell Drug Safety Workshop
3-5 July 2006; Oxford University, Oxford, UK
led by Saad Shakir, Director, Drug Safety Research Unit, UK
A. Leander Fontaine, President, pharmiceutics
Peter Elkin, Professor of Medicine, Mayo Clinic |
Take a closer look at the workshop programs. |
|
|
|
|
|
|
|
